Back in January this year, we summarised the key trends our market access experts believed would dom...
Read moreOur market access experts provide an overview of how to get payer scientific advice between Septembe...
Read morePayer value proposition development and understanding evidence requirements to secure pricing and re...
Read moreAlmost a decade after it's inception, what have we learned from the UK early access to medicines sch...
Read moreIntroduction Early Access Programs, also known as special access programs, give patients access to m...
Read moreThe report looks at four possible scenarios including most notably the creation of a “grande Sécu...
Read moreSecuring patient access in specialty products is becoming increasingly challenging due to the comple...
Read moreThis research highlights the variability regarding the scientific advice submission processes and sc...
Read moreThere are now European platforms for seeking early scientific advice with multiple payer organisatio...
Read moreThe aim of MAPPs is to enable quicker access for patients whilst providing adequate and evolving evi...
Read more